NYSE:CLColgate-Palmolive Stock Price, Forecast & News

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CL shares have increased by 10.7% and is now trading at $76.24.
View which stocks have been most impacted by Coronavirus.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Colgate-Palmolive.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) released its quarterly earnings data on Friday, July, 31st. The company reported $0.74 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.69 by $0.05. The company had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a net margin of 16.13% and a return on equity of 559.34%. The business's revenue was up .8% on a year-over-year basis. During the same period last year, the company posted $0.72 EPS.
View Colgate-Palmolive's earnings history.

Colgate-Palmolive declared a quarterly dividend on Thursday, June 11th. Investors of record on Monday, July 20th will be paid a dividend of $0.44 per share on Friday, August 14th. This represents a $1.76 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend is Friday, July 17th.
View Colgate-Palmolive's dividend history.

13 brokers have issued twelve-month price objectives for Colgate-Palmolive's shares. Their forecasts range from $58.00 to $88.00. On average, they expect Colgate-Palmolive's stock price to reach $75.82 in the next year. This suggests that the stock has a possible downside of 0.6%.
View analysts' price targets for Colgate-Palmolive.

News articles about CL stock have been trending somewhat positive this week, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Colgate-Palmolive earned a media sentiment score of 1.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days.
View the latest news about Colgate-Palmolive.

Some companies that are related to Colgate-Palmolive include Procter & Gamble (PG), Kimberly Clark (KMB), Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), PepsiCo (PEP), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Coca-Cola (KO), Mcdonald's (MCD) and Intel (INTC).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by a variety of institutional and retail investors. Top institutional investors include Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.40%), Sarasin & Partners LLP (0.39%), New York State Common Retirement Fund (0.26%), M&G Investment Management Ltd. (0.22%) and Confluence Investment Management LLC (0.19%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including ProShare Advisors LLC, Victory Capital Management Inc., Prudential PLC, Assenagon Asset Management S.A., 6 Meridian, Hexavest Inc., New York State Common Retirement Fund, and Confluence Investment Management LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, and Prabha Parameswaran.
View insider buying and selling activity for Colgate-Palmolive.

CL stock was acquired by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Conning Inc., Sarasin & Partners LLP, CIBC Asset Management Inc, LGT Capital Partners LTD., Mitsubishi UFJ Kokusai Asset Management Co. Ltd., Veracity Capital LLC, and Exchange Traded Concepts LLC.
View insider buying and selling activity for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CL stock can currently be purchased for approximately $76.24.

Colgate-Palmolive has a market capitalization of $65.37 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]